Business Services

Centogene

$11.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (+2.76%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Centogene and other stocks, options, and ETFs commission-free!

About CNTG

Centogene N.V. Common Shares, also called Centogene, is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Clinical Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Clinical Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark. The listed name for CNTG is Centogene N.V. Common Shares.

CEO
Andrin Oswald
Employees
442
Headquarters
Rostock, Mecklenburg-Vorpommern
Founded
2006
Market Cap
262.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
55.96K
High Today
$11.72
Low Today
$11.24
Open Price
$11.24
Volume
60.94K
52 Week High
$28.71
52 Week Low
$9.25

Collections

CNTG Earnings

-$14.17
-$9.45
-$4.72
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 22, Pre-Market

You May Also Like

CENX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure